Antibiotics
Study results from University of Alabama broaden understanding of antibiotics
Published in TB and Outbreaks Week, May 18th, 2010
Data detailed in 'A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis' have been presented. According to recent research published in the Journal of Infectious Diseases, "Syphilis remains an important source of morbidity worldwide. Long-acting penicillin is the only therapy currently recommended for syphilis in much of the world."
"Because of hesitation to use penicillin for fear of anaphylaxis, there is a need for an effective, well-tolerated alternative to penicillin for syphilis therapy. This multicenter, randomized clinical trial was conducted in clinics for the treatment of persons with sexually...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Syphilis
Data on syphilis published by researchers at University of New South Wales - Pandemics
New findings from University of Birmingham describe advances in pandemics - Meningitis
Data on meningitis reported by researchers at University of Utah, Huntsman Cancer Institute - Meningitis
New meningitis research from University of Texas, M. D. Anderson Cancer Center outlined - Epidemics
Research from University of Extremadura broadens understanding of epidemics - Epidemics
Researchers from University of Western Ontario describe findings in epidemics - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
